Xtx Topco LTD Iovance Biotherapeutics, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $83,751 - $165,805	18,863 New	18,863 $85,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $129,777 - $230,920	23,092 Added 127.74%	41,170 $263,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $172,283 - $237,002	18,078 New	18,078 $173,000
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $139,334 - $232,616	-8,419 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $171,326 - $224,197	8,419 New	8,419 $208,000

339

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $877M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.